IL325648A - תכשיר אלחוש ושיטת אלחוש העין - Google Patents
תכשיר אלחוש ושיטת אלחוש העיןInfo
- Publication number
- IL325648A IL325648A IL325648A IL32564825A IL325648A IL 325648 A IL325648 A IL 325648A IL 325648 A IL325648 A IL 325648A IL 32564825 A IL32564825 A IL 32564825A IL 325648 A IL325648 A IL 325648A
- Authority
- IL
- Israel
- Prior art keywords
- anesthetizing
- eye
- anesthetic composition
- anesthetic
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Anesthesiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962824207P | 2019-03-26 | 2019-03-26 | |
| PCT/US2019/024239 WO2019191200A1 (en) | 2018-03-27 | 2019-03-27 | Method and formulation for producing anesthesia of internal aspect of eye wall by topical application |
| US16/811,798 US11096922B2 (en) | 2018-03-27 | 2020-03-06 | Anesthetic composition and method of anesthetizing the eye |
| PCT/US2020/022915 WO2020197816A1 (en) | 2019-03-26 | 2020-03-16 | Anesthetic composition and method of anesthetizing the eye |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL325648A true IL325648A (he) | 2026-02-01 |
Family
ID=72609654
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL286624A IL286624B2 (he) | 2019-03-26 | 2020-03-16 | תכשיר אלחוש ושיטת אלחוש העין |
| IL325648A IL325648A (he) | 2019-03-26 | 2025-12-28 | תכשיר אלחוש ושיטת אלחוש העין |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL286624A IL286624B2 (he) | 2019-03-26 | 2020-03-16 | תכשיר אלחוש ושיטת אלחוש העין |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP3946311A4 (he) |
| JP (1) | JP2022527621A (he) |
| KR (2) | KR20210143254A (he) |
| CN (1) | CN114072139A (he) |
| AU (2) | AU2020245203A1 (he) |
| BR (1) | BR112021019039A2 (he) |
| CA (1) | CA3134531A1 (he) |
| IL (2) | IL286624B2 (he) |
| MX (1) | MX2021011589A (he) |
| SG (1) | SG11202110423UA (he) |
| WO (1) | WO2020197816A1 (he) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2038580T3 (es) * | 1989-08-03 | 1994-10-16 | Eisai Co Ltd | Metodo de fotoestabilizacion de soluciones oftalmicas. |
| DE69333850T3 (de) * | 1992-05-06 | 2011-03-17 | Alcon Laboratories, Inc., Fort Worth | Anwendung von boral-polyol-komplexen für ophthalmische arzneizusammensetzungen |
| US5972326A (en) * | 1995-04-18 | 1999-10-26 | Galin; Miles A. | Controlled release of pharmaceuticals in the anterior chamber of the eye |
| WO2003043660A2 (en) * | 2001-11-21 | 2003-05-30 | Novartis Ag | Composition for stabilizing hyaluronic acid |
| FR2882930B1 (fr) * | 2005-03-09 | 2009-03-27 | Walid Katib | Nouvelles compositions ophtalmologiques et leur mode d'utilisation |
| US20060229219A1 (en) * | 2005-04-11 | 2006-10-12 | Advanced Medical Optics, Inc. | Borate-polyol mixtures as a buffering system |
| JP5740906B2 (ja) * | 2009-10-21 | 2015-07-01 | 大正製薬株式会社 | 眼科用剤 |
| CN101695488B (zh) * | 2009-11-05 | 2012-05-02 | 蚌埠丰原涂山制药有限公司 | 复方阿替卡因注射用冻干制剂及其制备方法 |
| CN101721407B (zh) * | 2009-11-23 | 2013-04-10 | 蚌埠丰原涂山制药有限公司 | 复方盐酸阿替卡因注射液及其制备方法 |
| FR2968996B1 (fr) * | 2010-12-17 | 2013-04-12 | Anteis Sa | Formulation aqueuse injectable sterile utilisee en ophtalmologie |
| JP6185725B2 (ja) * | 2012-02-24 | 2017-08-23 | わかもと製薬株式会社 | 水性医薬組成物 |
| FR3036035B1 (fr) * | 2015-05-11 | 2018-10-05 | Laboratoires Vivacy | Compositions comprenant au moins un polyol et au moins un anesthesique |
| US20180250313A1 (en) * | 2015-09-08 | 2018-09-06 | Viewpoint Therapeutics, Inc. | Compounds and formulations for treating ophthalmic diseases |
| US12414937B2 (en) * | 2015-11-05 | 2025-09-16 | University Of Louisville Research Foundation, Inc. | Local and regional anesthesia and analgesia |
| WO2018220283A1 (fr) * | 2017-05-29 | 2018-12-06 | Kh Medtech Sarl | Composition injectable sterile contenant de l'acide hyaluronique reticule et de l'articaine |
-
2020
- 2020-03-16 EP EP20776365.7A patent/EP3946311A4/en active Pending
- 2020-03-16 MX MX2021011589A patent/MX2021011589A/es unknown
- 2020-03-16 BR BR112021019039A patent/BR112021019039A2/pt unknown
- 2020-03-16 CA CA3134531A patent/CA3134531A1/en active Pending
- 2020-03-16 AU AU2020245203A patent/AU2020245203A1/en not_active Abandoned
- 2020-03-16 WO PCT/US2020/022915 patent/WO2020197816A1/en not_active Ceased
- 2020-03-16 KR KR1020217034148A patent/KR20210143254A/ko not_active Ceased
- 2020-03-16 JP JP2021560140A patent/JP2022527621A/ja active Pending
- 2020-03-16 CN CN202080033483.9A patent/CN114072139A/zh active Pending
- 2020-03-16 KR KR1020267019877A patent/KR20260110244A/ko active Pending
- 2020-03-16 SG SG11202110423UA patent/SG11202110423UA/en unknown
- 2020-03-16 IL IL286624A patent/IL286624B2/he unknown
-
2025
- 2025-10-20 AU AU2025252666A patent/AU2025252666A1/en active Pending
- 2025-12-28 IL IL325648A patent/IL325648A/he unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022527621A (ja) | 2022-06-02 |
| KR20260110244A (ko) | 2026-07-14 |
| WO2020197816A1 (en) | 2020-10-01 |
| EP3946311A1 (en) | 2022-02-09 |
| MX2021011589A (es) | 2021-12-15 |
| EP3946311A4 (en) | 2022-12-28 |
| CA3134531A1 (en) | 2020-10-01 |
| KR20210143254A (ko) | 2021-11-26 |
| IL286624A (he) | 2021-10-31 |
| CN114072139A (zh) | 2022-02-18 |
| SG11202110423UA (en) | 2021-10-28 |
| IL286624B1 (he) | 2026-02-01 |
| AU2025252666A1 (en) | 2025-11-06 |
| IL286624B2 (he) | 2026-06-01 |
| AU2020245203A1 (en) | 2021-11-11 |
| BR112021019039A2 (pt) | 2021-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202106144VA (en) | Compositions for the delivery of therapeutic agents and methods of use and making thereof | |
| IL287720A (he) | מאפננים של thr-בתא ושיטות לשימוש בהם | |
| SG11202104158SA (en) | Composition and method for treating the lungs | |
| SG11202112978WA (en) | Auto-injector and related methods of use | |
| SG11202100533VA (en) | Hepato-biliary-pancreatic tissues and methods of making same | |
| IL284082A (he) | חומרי מילוי לרקמות משי-חומצה היאלורונית ושיטות להכנתם ולשימוש בהם | |
| IL327461A (he) | שיטות ותכשירים לטיפול במחלות נדירות | |
| IL292810A (he) | תרכובות טיפוליות ושיטות לשימוש | |
| IL276247A (he) | שיטות וחומרים לטיפול בדום נשימה בשינה | |
| IL276148A (he) | תכשיר ושיטה להפחתת מיעוט טסיות דם באמצעות מתן של פלינאבולין | |
| IL277151A (he) | מכשיר אספקת תרופה ושיטת שימושה ושיטת הכנתה | |
| IL285197A (he) | שיטות ותכשירים לטיפול בדום נשימה בשינה | |
| IL286697A (he) | תרכובות של נוירגולין-4 ושיטות לשימוש | |
| PT3675816T (pt) | Composições anestésicas de libertação prolongada e métodos de preparação das mesmas | |
| GB2589398B (en) | Compounds and methods of use | |
| IL276053A (he) | Gard טיפולי ושיטות לשימוש שלו | |
| IL287829A (he) | מאפננים של פרוגרנולין ושיטות לשימוש בהם | |
| IL276792A (he) | משאף ושיטות לשימוש בו | |
| IL277156A (he) | תכשירים ושיטות לטיפול בעמידות לאינסולין | |
| GB2579687B (en) | Composition and method | |
| IL282671A (he) | שיטות ותכשירים טיפוליים | |
| IL286624A (he) | תכשיר אלחוש ושיטת אלחוש העין | |
| GB201914777D0 (en) | Composition and method | |
| IL290548A (he) | חיידקים ושיטות לשימוש בהם | |
| GB2603379B (en) | Avocatin B for the treatment of diseases and conditions |